Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.
about
Induction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growthCystic fibrosis: exploiting its genetic basis in the hunt for new therapiesRecombinant, replication-defective adenovirus gene transfer vectors induce cell cycle dysregulation and inappropriate expression of cyclin proteins.Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organsAdenovirus-mediated gene expression in vivo is enhanced by the antiapoptotic bcl-2 gene.Common gene therapy viral vectors do not efficiently penetrate sputum from cystic fibrosis patients.The promise and potential hazards of adenovirus gene therapy.Bronchoalveolar fluid is not a major hindrance to virus-mediated gene therapy in cystic fibrosis.Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies.Adenovirus-mediated gene transfer to ciliated airway epithelia requires prolonged incubation time.Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigensFeline immunodeficiency virus vectors persistently transduce nondividing airway epithelia and correct the cystic fibrosis defectPrevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States.Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B.Adenovirus-mediated persistent cystic fibrosis transmembrane conductance regulator expression in mouse airway epithelium.Pseudopackaging of adenovirus type 5 genomes into capsids containing the hexon proteins of adenovirus serotypes B, D, or E.
P2860
Q33604559-04764F27-880E-45B7-9AE8-654ED4CF677FQ33664918-4FA5F735-CEBD-4843-90FB-C1BC207BC6A8Q33785925-36511E8B-ED99-491D-8FF8-5625D6952930Q33817535-6538B6AD-598D-4305-90FA-9AEE08851C61Q33818043-4BDEF2BE-8906-4D2F-BBCD-766456751491Q33921035-DFA6B3C3-3027-40BB-96E7-8A603CAEE7F8Q34219407-AF7F1604-66D9-4B13-AD2C-111D2B51E6A0Q34348149-2BB03215-3F3B-4C63-A175-0AF02BBD62FEQ35596728-CDC5A2CF-B4E9-495F-BDCC-53455FAC4518Q35870623-3B456F7D-ECA3-4770-908D-8354A606767FQ36473845-B8CFB9BC-E983-404A-A895-83D3797E3678Q36807130-5EB61EA2-A6B4-4678-8FC2-88577B514198Q37015368-3FD09BB8-4A8E-4D2E-8447-F982376EEE4EQ37363570-1F6D48C4-A854-49E6-987F-7C1002AFA203Q39580195-E3E1F4F0-A658-4092-99F0-FD257F5E7B17Q39601057-E1DF9E02-629B-433E-8983-8B398D0055B6
P2860
Humoral and cellular immune responses of nonhuman primates to long-term repeated lung exposure to Ad2/CFTR-2.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Humoral and cellular immune re ...... d lung exposure to Ad2/CFTR-2.
@en
Humoral and cellular immune re ...... d lung exposure to Ad2/CFTR-2.
@nl
type
label
Humoral and cellular immune re ...... d lung exposure to Ad2/CFTR-2.
@en
Humoral and cellular immune re ...... d lung exposure to Ad2/CFTR-2.
@nl
prefLabel
Humoral and cellular immune re ...... d lung exposure to Ad2/CFTR-2.
@en
Humoral and cellular immune re ...... d lung exposure to Ad2/CFTR-2.
@nl
P2093
P1433
P1476
Humoral and cellular immune re ...... d lung exposure to Ad2/CFTR-2.
@en
P2093
Johnson RP
Pennington SE
St George JA
Wadsworth SC
P304
P577
1996-02-01T00:00:00Z